T1	Participants 342 425	A5224s was a sub-study of A5202, a prospective trial of 1857 ART-naive participants
T2	Participants 763 913	A5224s included 269 participants: 85% men, 47% white non-Hispanic, median age 38 years, HIV-1 RNA 4.6 log10 copies/ml, and CD4 cell count 233 cells/Î¼l
